Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer
In qualified laboratory settings, researchers may reconstitute the contents with a suitable sterile solvent under aseptic technique to meet protocol requirements
Anisimov VN, Mylnikov SV, Oparina TI, Khavinson VK
BPC-157 (Body Protection Compound-157) is a research-backed peptide derived from a natural protein in the stomach
Semaglutide 2.4mg (GLP-1 Agonist): Proven GLP-1 effects (appetite suppression, gastric emptying) Already FDA-approved as Wegovy Established safety profile Cagrilintide 2.4mg (Amylin Analog): Mimics amylin, a hormone co-secreted with insulin Slows gastric emptying through different pathway than GLP-1 Reduces appetite through hindbrain (not hypothalamus) Improves postprandial glucose The Advantage: Leverages proven semaglutide efficacy and safety, adds complementary amylin effects
Enhances insulin sensitivity
US$ 26.05
US$ 27.92
US$ 28.14
US$ 25.60
US$ 28.75
